IPOPLUS

4,442.8

-23.9 -0.54%

18 Jun 2026

NSE Listed · Pharmaceuticals

Torrent Pharmaceuticals Limited (TORNTPHARM)

Volume: 5,798Avg Vol 1W: 12,072Avg Vol 1M: 14,21252W Range:3,140.14,712.9
₹4,442.8 0.54%
Market Cap₹1,54,837 Cr
Current Price₹4,442.8
Previous Close₹4,466.7
High / Low (52w)₹4,712.9 / ₹3,140.1
Volume5,798
Avg Vol (1W)12,072
Avg Vol (1M)14,212
Stock P/E66.03
Book Value₹247.86
Dividend Yield0.83%
ROE25.49%
ROA4.82%
Revenue (TTM)
Revenue Growth21.39%
Profit Margin15.55%
Total Debt₹11,651 Cr
Shares Outstanding34 Cr
Face Value₹5
EPS (TTM)₹11.51
P/B18.22
Debt / Equity1.79
50 DMA₹4,349.94
200 DMA₹4,185.15
Day change-0.54%
Price Chart
4,442.8 24.61% · 1Y
4575343716.4L
2025-10-01
2026-06-16

20-day avg volume: 15K shares

Pros
  • Healthy return on equity of 25.5%.
  • Company is almost debt-free.
  • Revenue grew 20% YoY.
  • Net profit is growing year over year.
Cons
  • Stock trades at a high P/E of 66.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021Mar 2021Dec 2020Sept 2020Jun 2020Mar 2020
Revenue₹4,197 Cr₹3,303 Cr₹3,302 Cr₹3,178 Cr₹2,959 Cr₹2,809 Cr₹2,889 Cr₹2,859 Cr₹2,745 Cr₹2,732 Cr₹2,660 Cr₹2,591 Cr₹2,491 Cr₹2,491 Cr₹2,291 Cr₹2,347 Cr₹2,131 Cr₹2,108 Cr₹2,137 Cr₹2,134 Cr₹1,937 Cr₹1,995 Cr₹2,017 Cr₹2,056 Cr₹1,946 Cr
EBITDA₹831 Cr₹869 Cr₹852 Cr₹794 Cr₹745 Cr₹748 Cr₹725 Cr₹731 Cr₹711 Cr₹623 Cr₹650 Cr₹634 Cr₹540 Cr₹521 Cr₹532 Cr₹587 Cr₹455 Cr₹419 Cr₹543 Cr₹552 Cr₹456 Cr₹448 Cr₹476 Cr₹504 Cr₹395 Cr
Net Profit₹364 Cr₹635 Cr₹591 Cr₹548 Cr₹498 Cr₹503 Cr₹453 Cr₹457 Cr₹449 Cr₹443 Cr₹386 Cr₹378 Cr₹287 Cr₹292 Cr₹312 Cr₹354 Cr₹-118 Cr₹249 Cr₹316 Cr₹330 Cr₹324 Cr₹297 Cr₹310 Cr₹321 Cr₹314 Cr
EPS11.5118.7717.5416.1914.7114.8813.3713.5113.2713.111.3911.188.488.639.2220.9-6.9714.7518.6319.5319.1617.5218.3218.9818.56
Profit & Loss (Annual)
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹13,886 Cr₹11,539 Cr₹10,786 Cr₹9,665 Cr₹8,705 Cr₹8,061 Cr₹8,061 Cr
EBITDA₹3,346 Cr₹2,949 Cr₹2,617 Cr₹2,181 Cr₹1,966 Cr₹1,879 Cr₹1,637 Cr
Net Profit₹2,163 Cr₹1,911 Cr₹1,656 Cr₹1,245 Cr₹777 Cr₹1,252 Cr₹1,025 Cr
EPS63.9256.4748.9436.7922.9673.9860.55
Balance Sheet
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹44,312 Cr₹14,990 Cr₹15,061 Cr₹15,012 Cr₹13,100 Cr₹14,075 Cr₹14,010 Cr
Total Liabilities₹26,727 Cr₹7,399 Cr₹8,204 Cr₹8,814 Cr₹7,147 Cr₹8,237 Cr₹9,187 Cr
Equity₹17,585 Cr₹7,591 Cr₹6,856 Cr₹6,198 Cr₹5,953 Cr₹5,837 Cr₹4,823 Cr
Total Debt₹11,651 Cr₹1,192 Cr₹1,604 Cr₹2,496 Cr₹2,123 Cr₹2,941 Cr₹3,275 Cr
Cash Flow
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating₹3,832 Cr₹3,188 Cr₹3,764 Cr₹2,766 Cr₹2,224 Cr₹2,181 Cr₹1,677 Cr
Investing₹-12,712 Cr₹-540 Cr₹-168 Cr₹-2,415 Cr₹-197 Cr₹-449 Cr₹199 Cr
Financing₹10,151 Cr₹-2,298 Cr₹-2,780 Cr₹77 Cr₹-1,781 Cr₹-1,651 Cr₹-1,549 Cr
Free Cash Flow₹3,832 Cr₹3,188 Cr₹3,764 Cr₹2,766 Cr₹2,224 Cr₹2,181 Cr₹1,677 Cr
Shareholding
Promoter 68.31% Institutions 25.24% Public 6.45%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search